Comment on "Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease"

dc.contributor.authorUlaş, Turgay
dc.contributor.authorDal, Mehmet Sinan
dc.contributor.authorDemir, Mehmet Emin
dc.contributor.authorBüyükhatipoǧlu, Hakan
dc.date.accessioned2024-04-24T17:56:52Z
dc.date.available2024-04-24T17:56:52Z
dc.date.issued2012
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.description.abstract[No abstract available]en_US
dc.identifier.citationUlaş, T., Dal, M. S., Demir, M. E. ve Büyükhatipoǧlu, H. (2012). Comment on "Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease". Polskie Archiwum Medycyny Wewnetrznej, 122(6), 306.
dc.identifier.doi10.20452/pamw.1322
dc.identifier.issn0032-3772
dc.identifier.issue6en_US
dc.identifier.pmid22751293
dc.identifier.scopus2-s2.0-84863762271
dc.identifier.scopusqualityQ2
dc.identifier.startpage306en_US
dc.identifier.urihttps://doi.org/10.20452/pamw.1322
dc.identifier.urihttps://hdl.handle.net/11468/23692
dc.identifier.volume122en_US
dc.identifier.wosWoSIDEksik
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherMedycyna Praktycznaen_US
dc.relation.ispartofPolskie Archiwum Medycyny Wewnetrznej
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleComment on "Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease"en_US
dc.titleComment on "Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease"
dc.typeLetteren_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
Comment on Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver diseas.pdf
Boyut:
60.26 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası